SCLX FY 2021 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$73M

FY 2021 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$31M+32.9% YoY

Gross Profit

$28M88.4% margin

Operating Income

-$36M-114.4% margin

Net Income

-$88M-282.4% margin

EPS (Diluted)

$-23.29

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$29M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$78M

Total Liabilities

$302M

Stockholders' Equity

-$224M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$24M	+32.9%
Gross Profit	$28M	$21M	+29.3%
Operating Income	-$36M	-$35M	-1.6%
Net Income	-$88M	-$48M	-86.1%